Ron Eastman
Managing Director, Palo Alto- B.A.
- Williams College
- M.B.A.
- Columbia University
Ron Eastman has over 30 years of experience in building healthcare businesses. He began his career at American Cyanamid Company, where Mr. Eastman spent 15 years managing various pharmaceutical products, divisions and subsidiaries in the U.S. and overseas. Since then, he has helped build three private healthcare companies—Geron, HCORP, and Rinat Neuroscience.
Under his leadership, Geron became a cutting-edge biotech company which grew from a venture-backed startup to a publicly traded pioneer in the fields of regenerative medicine and cancer. HCORP quickly established itself as the technology and market leader in the emerging field of hospital-based, interactive patient services and was sold to a diversified competitor. Most recently, at Rinat, a private biotech company spun out of Genentech with the support of Essex Woodlands in late 2001, Mr. Eastman led the effort to build the first company dedicated to discovering and developing large molecule drugs for treating nervous system disorders. Rinat was acquired by Pfizer for $500M in 2006.
Mr. Eastman joined Essex Woodlands in the Palo Alto office in October 2006 and is a Managing Director.
